Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:45 Issue:1 Number:4 ISSN#:2564-2537
ACE Report #13651
Ace Report Cover Peri-Operative

COA2021: Effect of Oral Anticoagulant Use on Surgical Delay & Mortality in Hip Fracture Patients

How to Cite

OrthoEvidence. COA2021: Effect of Oral Anticoagulant Use on Surgical Delay & Mortality in Hip Fracture Patients. ACE Report. 2021;45(1):4. Available from: https://myorthoevidence.com/AceReport/Report/13651

Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:1

Effect of Oral Anticoagulant Use on Surgical Delay and Mortality in Hip Fracture: A Systematic Review and Meta-Analysis


Contributing Authors: D You Y Xu B Ponich P Ronksley L Skeith R Korley M Carrier P Schneider

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.


Thirty-four studies involving 39,446 patients were included in this systematic review and meta-analysis comparing anticoagulated patients and non-anticoagulated patients. Outcomes of interest included the time to surgery, odds of having surgery beyond the recommended 48 hours from admission, and the odds of 30-day all cause mortality. Pooled comparisons between direct oral anticoagulants and Vitam...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.